Home
>
National Drug Code (NDC)
>
Tizanidine
Tizanidine - 43063-455-30 - (Tizanidine)
Drug Information of Tizanidine
| Product NDC: | 43063-455 |
| Proprietary Name: | Tizanidine |
| Non Proprietary Name: | Tizanidine |
| Active Ingredient(s): | 4 mg/1 & nbsp; Tizanidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tizanidine
| Product NDC: | 43063-455 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076286 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020703 |
Package Information of Tizanidine
| Package NDC: | 43063-455-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (43063-455-30) |
NDC Information of Tizanidine
| NDC Code | 43063-455-30 |
| Proprietary Name | Tizanidine |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (43063-455-30) |
| Product NDC | 43063-455 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tizanidine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020703 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
